| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.05B | -1.0% |
| Cost of Revenue | $603.9M | -4.5% |
| Gross Profit | $444.8M | +4.2% |
| R&D Expense | $10.9M | +14.7% |
| SG&A Expense | $296.3M | +4.3% |
| Operating Income | $142.3M | +85.3% |
| Pre-tax Income | $94.4M | +150.4% |
| Income Tax | $21.5M | -30.2% |
| Net Income | $72.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.3M | -36.1% |
| Inventory | $138.8M | -2.7% |
| Current Assets | $512.3M | -21.2% |
| Total Assets | $2.49B | -0.3% |
| Current Liabilities | $198.0M | +0.8% |
| Long-term Debt | $640.1M | -1.0% |
| Total Liabilities | $1.06B | -0.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $29.1M | -14.2% |
| Financing Cash Flow | -$50.5M | +70.5% |
| +228.4% |
| EPS (Basic) | $3.48 | +228.3% |
| EPS (Diluted) | $3.45 | +228.6% |
| Stockholders' Equity |
| $1.43B |
| +1.3% |